Aravindhan Veerapandiyan, MD
Dr. Veerapandiyan is the Director of the Comprehensive Neuromuscular Program at Arkansas Children's Hospital. He is an Associate Professor in the Department of Pediatrics, section of neurology at University of Arkansas for Medical Sciences. He serves as the Director of the PPMD Certified Duchenne Care Center and Co-Director of the Muscular Dystrophy Association Care Center at Arkansas Children's Hospital. Dr. Veerapandiyan earned his medical degree from the K.A.P. Vishwanatham Government Medical College in India. He completed a residency in Child Neurology at Rutgers University – New Jersey Medical School in Newark, New Jersey and a fellowship in Neuromuscular Medicine at University of Rochester – Strong Memorial Hospital in Rochester, New York. Dr. Veerapandiyan has a passion for clinical research and education. He has published more than 50 peer-reviewed articles and has presented his work at national meetings. He is actively involved in industry-sponsored clinical trials focusing on neuromuscular disorders in children.
Financial relationships
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:Biogen, Novartis, AveXis, Sarepta therapeutics, PTC therapeutics, Scholar Rock, Fibrogen, AMO pharma, Pfizer, Edgewise therapeuticsTopic:Ad Hoc Advisory boardsDate added:12/22/2022
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:Sarepta, Fibrogen, Pfizer, Octapharma, Regenxbio, Edgewise therapeutics, Amgen, Lilly, Teva therapeutics, Impax, Capricor therapeutics, Muscular Dystrophy Association, Parent Project Muscular Dystrophy, and France FoundationTopic:Research / Grant SupportDate added:12/22/2022